Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
3
60%
Ph phase_4
1
20%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (60.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

terminated120%
completed360%
not_yet_recruiting120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_2

Metformin and Alveolar Cleft

NCT07536620
completedphase_2

Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma

NCT01840007
terminatednot_applicable

Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese Adolescents

NCT00889876
completedphase_2

Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.

NCT04148183
completedphase_4

Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

NCT01947790

Clinical Trials (5)

Showing 5 of 5 trials
NCT07536620Phase 2

Metformin and Alveolar Cleft

Not Yet Recruiting
NCT01840007Phase 2

Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma

Completed
NCT00889876Not Applicable

Effect of Exercise or Metformin on Nocturnal Blood Pressure and Other Risk Factors for CVD Among Obese Adolescents

Terminated
NCT04148183Phase 2

Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.

Completed
NCT01947790Phase 4

Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5